APRINOIA Therapeutics Inc.

[On Demand]

APRINOIA Therapeutics Inc. with operations in Hong Kong, Taipei, Tokyo, Suzhou, Shanghai, and Boston, was founded in May 2015. APRINOIA is a drug discovery and development company. Our goal is to create novel products to meet critical needs of patients suffering from neurodegenerative diseases. The current pipeline includes imaging-based diagnostics and therapeutics developed from two drug discovery platforms.

Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Hong Kong
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
18F-APN-1607 tau diagnostic PET tracer,APNmAb005 monoclonal antibody therapeutic,protein degradation
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Aprinoia Therapeutics